Although the impaired internalization of PAR1 that results with persistent signaling and invasion was previously suggested for several breast cancer lines [17], an imbalanced expression between hPar1 repressors and activators was proposed, suggesting transcriptional regulation [18]. This evidence concerns the gene F2R and breast cancer.